Betta Pharmaceuticals Hits Day Low of CNY 65.03 Amid Price Pressure

Betta Pharmaceuticals Co., Ltd. experienced a notable decline today, with the stock dropping by 4.73% as it reached an intraday low of CNY 65.03. This performance stands in contrast to the China Shanghai Composite, which fell by only 0.94% on the same day. Over the past week, Betta Pharmaceuticals has seen a decrease of 2.29%, while its monthly performance reflects a more significant drop of 9.23%.
Despite the recent downturn, the company has shown resilience over the longer term, boasting a 38.89% increase in stock value over the past year, significantly outperforming the China Shanghai Composite's 18.02% gain. Year-to-date, Betta Pharmaceuticals has achieved a 21.05% increase, and its three-year performance stands at an impressive 47.36%.

Key financial metrics indicate a market capitalization of CNY 27,699 million, a P/E ratio of 72.00, and a dividend yield of 0.30%. The company's return on equity is reported at 6.92%, with a price-to-book ratio of 4.95. These figures highlight Betta Pharmaceuticals' position within the pharmaceuticals and biotechnology industry, despite today's stock activity.